$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223022546 Filed on June 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$205.9K	$52.68K	$238.7K
YoY Change	466.58%	207.53%	606.8%
Cost Of Revenue	$49.74K	$200.9K	$200.9K
YoY Change
Gross Profit	$156.1K	-$148.2K	$37.83K
YoY Change	329.69%		12.05%
Gross Profit Margin	75.84%	-281.26%	15.85%
Selling, General & Admin	$1.657M	$1.754M	$7.860M
YoY Change	-10.82%	-96.18%	-84.85%
% of Gross Profit	1061.1%		20776.04%
Research & Development		$0.00	$190.9K
YoY Change		-100.0%	-53.21%
% of Gross Profit			504.48%
Depreciation & Amortization	$435.0K	$813.1K	$1.795M
YoY Change	-17.14%	-25.28%	-17.98%
% of Gross Profit	278.61%		4744.66%
Operating Expenses	$2.459M	$2.521M	$11.32M
YoY Change	-15.88%	-94.63%	-79.23%
Operating Profit	-$2.303M	-$2.669M	-$11.28M
YoY Change	-20.23%		-79.28%
Interest Expense	$178.7K	-$1.315M	-$5.772M
YoY Change	-73.98%	41.24%	71.0%
% of Operating Profit
Other Income/Expense, Net	$4.456K	$124.2K	-$4.710M
YoY Change	-99.35%		-83.98%
Pretax Income	-$2.298M	-$4.435M	-$15.99M
YoY Change	4.47%	-90.67%	-81.47%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.298M	-$4.495M	-$15.99M
YoY Change	4.47%	-90.54%	-81.47%
Net Earnings / Revenue	-1116.44%	-8533.24%	-6698.38%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	868.0M shares	783.2M shares	748.5M shares
Diluted Shares Outstanding	839.7M shares		748.5M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$69.77K	$216.5K	$216.5K
YoY Change	-89.5%	-87.52%	-87.52%
Cash & Equivalents	$69.77K	$216.5K
Short-Term Investments
Other Short-Term Assets	$1.646M	$1.623M	$1.623M
YoY Change	-17.43%	-46.11%	-46.11%
Inventory	$46.66K	$25.73K	$25.73K
Prepaid Expenses	$254.1K	$286.6K
Receivables	$36.33K	$17.33K	$17.33K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.799M	$1.882M	$1.882M
YoY Change	-35.78%	-61.02%	-61.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.63M	$15.04M	$15.27M
YoY Change	-7.4%	1.66%	-5.53%
Goodwill
YoY Change
Intangibles		$6.269M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.27M	$15.66M	$20.63K
YoY Change	-9.33%	-14.29%	0.0%
Total Long-Term Assets	$29.91M	$30.70M	$30.70M
YoY Change	-8.39%	-7.15%	-7.15%
TOTAL ASSETS
Total Short-Term Assets	$1.799M	$1.882M	$1.882M
Total Long-Term Assets	$29.91M	$30.70M	$30.70M
Total Assets	$31.71M	$32.59M	$32.59M
YoY Change	-10.56%	-14.02%	-14.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.545M	$3.510M	$3.510M
YoY Change	9.02%	25.24%	25.24%
Accrued Expenses	$2.228M	$1.315M	$2.946M
YoY Change	919.56%	533.97%	165.07%
Deferred Revenue
YoY Change
Short-Term Debt	$760.2K	$760.2K	$760.2K
YoY Change	47.49%	47.49%	47.49%
Long-Term Debt Due	$3.381M	$3.071M	$3.071M
YoY Change	3421.56%	3099.06%	3099.06%
Total Short-Term Liabilities	$10.58M	$11.22M	$11.22M
YoY Change	-46.23%	-48.63%	-48.63%
LONG-TERM LIABILITIES
Long-Term Debt	$21.87M	$21.31M	$21.31M
YoY Change	359.0%	675.41%	675.41%
Other Long-Term Liabilities	$106.2K	$125.2K	$125.2K
YoY Change	-60.42%	-56.27%	-56.27%
Total Long-Term Liabilities	$21.98M	$21.44M	$21.44M
YoY Change	336.64%	606.4%	606.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.58M	$11.22M	$11.22M
Total Long-Term Liabilities	$21.98M	$21.44M	$21.44M
Total Liabilities	$32.56M	$32.66M	$32.66M
YoY Change	31.75%	31.27%	31.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$170.2M	-$167.5M
YoY Change	11.44%	11.66%
Common Stock	$86.89K	$80.38K
YoY Change	17.27%	19.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$46.26M	-$45.69M	-$73.61K
YoY Change
Total Liabilities & Shareholders Equity	$31.71M	$32.59M	$32.59M
YoY Change	-10.56%	-14.02%	-14.02%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$2.298M	-$4.495M	-$15.99M
YoY Change	4.47%	-90.54%	-81.47%
Depreciation, Depletion And Amortization	$435.0K	$813.1K	$1.795M
YoY Change	-17.14%	-25.28%	-17.98%
Cash From Operating Activities	-$1.401M	-$1.974M	-$5.859M
YoY Change	-31.81%	427.48%	-53.41%
INVESTING ACTIVITIES
Capital Expenditures	$39.31K	$118.3K	$2.548M
YoY Change	-108.0%	-122.19%	-150.14%
Acquisitions
YoY Change
Other Investing Activities	$19.00K	$0.00	$700.0K
YoY Change			-120.9%
Cash From Investing Activities	-$20.31K	-$118.3K	-$1.848M
YoY Change	-95.86%	-77.81%	-78.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.275M	2.167M	$6.190M
YoY Change	-13.65%	-9128.12%	-72.6%
NET CHANGE
Cash From Operating Activities	-$1.401M	-1.974M	-$5.859M
Cash From Investing Activities	-$20.31K	-118.3K	-$1.848M
Cash From Financing Activities	$1.275M	2.167M	$6.190M
Net Change In Cash	-$146.7K	74.60K	-$1.518M
YoY Change	-86.29%	-108.01%	-196.16%
FREE CASH FLOW
Cash From Operating Activities	-$1.401M	-$1.974M	-$5.859M
Capital Expenditures	$39.31K	$118.3K	$2.548M
Free Cash Flow	-$1.440M	-$2.092M	-$8.407M
YoY Change	-7.88%	-1417.89%	12.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001465470
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2022Q1	SHMP	Restructured August Note Payable RestructuredAugustNotePayable		usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q1	us-gaap	Senior Notes SeniorNotes		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023	SHMP	General And Administrative Expense Stock Compensation GeneralAndAdministrativeExpenseStockCompensation		usd
CY2023	SHMP	Financing Costs FinancingCosts		usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
CY2023	SHMP	Gain On Debt Settlement GainOnDebtSettlement		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	SHMP	Gain On Settlement Of Accrued Expenses GainOnSettlementOfAccruedExpenses		usd
CY2023	us-gaap	Legal Fees LegalFees		usd
CY2022	us-gaap	Loss From Catastrophes LossFromCatastrophes		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares		usd
CY2022	SHMP	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	SHMP	Common Shares Issued For Technical Rights Agreement CommonSharesIssuedForTechnicalRightsAgreement		usd
CY2022	SHMP	Common Shares Issued For Acquisition Of Noncontrolling Interest And Patent Acquisition CommonSharesIssuedForAcquisitionOfNoncontrollingInterestAndPatentAcquisition		usd
CY2022	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2023	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature		usd
CY2023	SHMP	Common Stock Issued In Business Agreement To Be Paid From Revenue Earned CommonStockIssuedInBusinessAgreementToBePaidFromRevenueEarned		usd
CY2023	SHMP	Common Stock Issued From Shares Payable CommonStockIssuedFromSharesPayable		usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Loss From Catastrophes LossFromCatastrophes		usd
CY2023	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
CY2023	SHMP	Gain On Debt Settlement GainOnDebtSettlement		usd
CY2023	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements		usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2022	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Proceeds From Removal Costs ProceedsFromRemovalCosts		usd
CY2023	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition		usd
CY2023	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci		usd
CY2023	SHMP	Cash Paid For License Agreement CashPaidForLicenseAgreement		usd
CY2023	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess		usd
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2023	SHMP	Payments Due On License Agreement Revised For March312022 PaymentsDueOnLicenseAgreementRevisedForMarch312022		usd
CY2023	SHMP	Repayment Of License Agreement RepaymentOfLicenseAgreement		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	SHMP	Proceeds From Promissory Note Related Parties ProceedsFromPromissoryNoteRelatedParties		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt		usd
CY2023	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture		usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023	SHMP	Proceeds From Sale Of Series E Ps ProceedsFromSaleOfSeriesEPs		usd
CY2023	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets		usd
CY2023	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures		usd
CY2023	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind		usd
CY2023	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition		usd
CY2023	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci		usd
CY2023	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1		shares
CY2023	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement		usd
CY2021Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	SHMP	Reclass To Equity Upon Conversion Or Redemption ReclassToEquityUponConversionOrRedemption		usd
CY2023	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities		usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2023	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability		usd
CY2023	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
CY2021Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
CY2022	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement		usd
CY2022	SHMP	Change In Fair Value Of Restructed Notes ChangeInFairValueOfRestructedNotes		usd
CY2022Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54030
CY2023	dei	Entity Registrant Name EntityRegistrantName	NATURALSHRIMP INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3262176
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5501 LBJ Freeway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 450
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
CY2023	dei	City Area Code CityAreaCode	(888)
CY2023	dei	Local Phone Number LocalPhoneNumber	791-9474
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	102234878	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	867995962	shares
CY2023	dei	Auditor Firm AuditorFirmId	76
CY2023	dei	Auditor Name AuditorName	Turner, Stone & Company, L.L.P
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q1	us-gaap	Cash Cash	216465	usd
CY2022Q1	us-gaap	Cash Cash	1734040	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17325	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14385	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	1500000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	25725	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	69170	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	286593	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1511546	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1336263	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1882371	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	4829141	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15043715	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2023Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	25130	usd
CY2022Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1087101	usd
CY2023Q1	SHMP	Intangible Assets Nets Excluding Goodwill IntangibleAssetsNetsExcludingGoodwill	6268500	usd
CY2022Q1	SHMP	Intangible Assets Nets Excluding Goodwill IntangibleAssetsNetsExcludingGoodwill	6658500	usd
CY2023Q1	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	9142376	usd
CY2022Q1	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	10222376	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	204243	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	282753	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2022Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15660882	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18271363	usd
CY2023Q1	us-gaap	Assets Assets	32586968	usd
CY2022Q1	us-gaap	Assets Assets	37898607	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3510206	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2802787	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	923387	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	500450	usd
CY2023Q1	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	219542	usd
CY2022Q1	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	203520	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1314961	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	207418	usd
CY2023Q1	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	400306	usd
CY2022Q1	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	200000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20044	usd
CY2023Q1	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2400000	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	579248	usd
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	296630	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13101000	usd
CY2023Q1	SHMP	Warrant Liability WarrantLiability	355000	usd
CY2022Q1	SHMP	Warrant Liability WarrantLiability	3923000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87804	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11221783	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21846261	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9680000	usd
CY2022Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2629079	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	21290000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	23604	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	119604	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	125189	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	286253	usd
CY2023Q1	us-gaap	Liabilities Liabilities	32660576	usd
CY2022Q1	us-gaap	Liabilities Liabilities	24881197	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	803123748	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	803123748	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	674831624	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	674644124	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	80377	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	67500	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121156733	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96701607	usd
CY2023Q1	SHMP	Stock To Be Issued StockToBeIssued	-662767	usd
CY2022Q1	SHMP	Stock To Be Issued StockToBeIssued	-20132650	usd
CY2023Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167533292	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150036023	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-45689165	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-33133766	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32586968	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37898607	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238685	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33765	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	200853	usd
CY2023	us-gaap	Gross Profit GrossProfit	37832	usd
CY2022	us-gaap	Gross Profit GrossProfit	33765	usd
CY2023	SHMP	General Administratives Expenses GeneralAdministrativesExpenses	2415749	usd
CY2022	SHMP	General Administratives Expenses GeneralAdministrativesExpenses	2666651	usd
CY2023	SHMP	General And Administrative Expense Rent GeneralAndAdministrativeExpenseRent	89524	usd
CY2022	SHMP	General And Administrative Expense Rent GeneralAndAdministrativeExpenseRent	72417	usd
CY2023	SHMP	General And Administrative Expense Salaries And Wages GeneralAndAdministrativeExpenseSalariesAndWages	2060237	usd
CY2022	SHMP	General And Administrative Expense Salaries And Wages GeneralAndAdministrativeExpenseSalariesAndWages	2292849	usd
CY2022	SHMP	General And Administrative Expense Stock Compensation GeneralAndAdministrativeExpenseStockCompensation	43704900	usd
CY2023	SHMP	General And Administrative Expense Professional Services GeneralAndAdministrativeExpenseProfessionalServices	1358185	usd
CY2022	SHMP	General And Administrative Expense Professional Services GeneralAndAdministrativeExpenseProfessionalServices	2044001	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5923695	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50780818	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190855	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	407874	usd
CY2023	SHMP	Facility Operations FacilityOperations	1936296	usd
CY2022	SHMP	Facility Operations FacilityOperations	1097745	usd
CY2023	us-gaap	Depreciation Depreciation	1795427	usd
CY2022	us-gaap	Depreciation Depreciation	1307038	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1470000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	881500	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	11316273	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	54474975	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-11278441	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-54441210	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5019883	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2616364	usd
CY2022	SHMP	Financing Costs FinancingCosts	1904074	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-116000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3568000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1987000	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-2842132	usd
CY2022	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan	103200	usd
CY2022	SHMP	Gain On Debt Settlement GainOnDebtSettlement	815943	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
CY2023	SHMP	Extension Fee ExtensionFee	-575100	usd
CY2023	SHMP	Gain On Settlement Of Accrued Expenses GainOnSettlementOfAccruedExpenses	124202	usd
CY2022	us-gaap	Legal Fees LegalFees	29400000	usd
CY2023	us-gaap	Loss From Catastrophes LossFromCatastrophes	869379	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4709579	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31856538	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15988020	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86297748	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15988020	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-86297748	usd
CY2023	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-212048	usd
CY2022	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-3349198	usd
CY2023	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	755333	usd
CY2022	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	337834	usd
CY2022	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	-5792947	usd
CY2023	us-gaap	Dividends Dividends	541868	usd
CY2022	us-gaap	Dividends Dividends	575029	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17497269	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-96352756	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	748525497	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	619123768	shares
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3070969	usd
CY2022	SHMP	Issuance Of Common Stock Upon Conversion Value IssuanceOfCommonStockUponConversionValue	421486	usd
CY2022	SHMP	Exchange Of Series D Ps To Series E Ps ExchangeOfSeriesDPsToSeriesEPs	-3258189	usd
CY2022	SHMP	Sale Of Common Shares And Warrants For Cash Less Offering Costs And Commitment Shares Amount SaleOfCommonSharesAndWarrantsForCashLessOfferingCostsAndCommitmentSharesAmount	17277123	usd
CY2022	SHMP	Exercise Of Warrants Related To The Sale Of Common Shares Amount ExerciseOfWarrantsRelatedToTheSaleOfCommonSharesAmount	11000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3439219	usd
CY2022	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-3349198	usd
CY2022	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	2534758	usd
CY2022	SHMP	Common Shares To Be Issued For Acquisition Of Noncontrolling Interest Subsidiarys Remaining Equity CommonSharesToBeIssuedForAcquisitionOfNoncontrollingInterestSubsidiarysRemainingEquity	1000000	usd
CY2022	SHMP	Common Shares To Be Issued For Patent Acquisition CommonSharesToBeIssuedForPatentAcquisition	5000000	usd
CY2022	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	221472	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	158333	usd
CY2022	SHMP	Common Stock Issued To Employees Amount CommonStockIssuedToEmployeesAmount	107572	usd
CY2022	SHMP	Common Shares To Be Issued For Technical Rights Agreement CommonSharesToBeIssuedForTechnicalRightsAgreement	4762376	usd
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	182639	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2880001	usd
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	392390	usd
CY2022	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	278400	usd
CY2022	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	337834	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-2935000	usd
CY2022	SHMP	Common Stock To Be Issued For Legal Settlement To Nsh Shareholders CommonStockToBeIssuedForLegalSettlementToNshShareholders	29388000	usd
CY2022	SHMP	Common Stock Issued For Financing Expense CommonStockIssuedForFinancingExpense	138040	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-86297748	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33133765	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33133765	usd
CY2023	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	3075745	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1560000	usd
CY2023	SHMP	Increase Of10 In Series E Preferred Shares To One Holder Based On Certain Rights IncreaseOf10InSeriesEPreferredSharesToOneHolderBasedOnCertainRights	-156000	usd
CY2023	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-113048	usd
CY2023	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	755333	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	277868	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26000	usd
CY2023	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	73124	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15988020	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-45689165	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-45689165	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15988020	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-86297748	usd
CY2023	us-gaap	Depreciation Depreciation	1795427	usd
CY2022	us-gaap	Depreciation Depreciation	1307038	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1470000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	881500	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5019883	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2616364	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-116000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3568000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1987000	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-2842132	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	575100	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1890072	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
CY2023	us-gaap	Loss From Catastrophes LossFromCatastrophes	869379	usd
CY2022	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan	103200	usd
CY2022	SHMP	Gain On Debt Settlement GainOnDebtSettlement	815943	usd
CY2022	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	29388000	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	99124	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	44099376	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78510	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2940	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14385	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43445	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	69170	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1224953	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	856207	usd
CY2023	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	1336263	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	712169	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	342948	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1107543	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-79007	usd
CY2023	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	200306	usd
CY2022	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	200000	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2249932	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	440118	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	16022	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	16000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-73260	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5858646	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8925244	usd
CY2023	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	2548447	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1452652	usd
CY2023	us-gaap	Proceeds From Removal Costs ProceedsFromRemovalCosts	700000	usd
CY2022	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition	2000000	usd
CY2022	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	1000000	usd
CY2022	SHMP	Cash Paid For License Agreement CashPaidForLicenseAgreement	2350000	usd
CY2022	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1629813	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1848447	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8432465	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	214852	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	96000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4596000	usd
CY2023	SHMP	Repayments Of Notes Payable Related Party RepaymentsOfNotesPayableRelatedParty	5000	usd
CY2022	SHMP	Repayments Of Notes Payable Related Party RepaymentsOfNotesPayableRelatedParty	655750	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	227	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	553577	usd
CY2022	SHMP	Payments Due On License Agreement Revised For March312022 PaymentsDueOnLicenseAgreementRevisedForMarch312022	1250000	usd
CY2022	SHMP	Repayment Of License Agreement RepaymentOfLicenseAgreement	2400000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17277123	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3075745	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1465000	usd
CY2023	SHMP	Proceeds From Promissory Note Related Parties ProceedsFromPromissoryNoteRelatedParties	250000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	8905000	usd
CY2023	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt	1500000	usd
CY2022	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture	5000000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	421486	usd
CY2022	SHMP	Proceeds From Sale Of Series E Ps ProceedsFromSaleOfSeriesEPs	1348000	usd
CY2022	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs	-3513504	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6189518	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18935954	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1517575	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1578245	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1734040	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155795	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216465	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1734040	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	7472	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	212190	usd
CY2023	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets	1061971	usd
CY2022	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures	421486	usd
CY2023	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock	1668000	usd
CY2022	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock	2880000	usd
CY2022	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability	275400	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	332566	usd
CY2022	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	278400	usd
CY2022	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition	5000000	usd
CY2022	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci	2000000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4762376	shares
CY2022	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement	29388000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zG5aKGJg9y6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82F_zFfuVxVQk3qg">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of the Business</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation, NaturalShrimp Global, Inc. and Natural Aquatic Systems, Inc. (“NAS”), and owns <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HydrenesisLLCMember_zFZBIyoEf7Je" title="Ownership percentage">51</span>% of NaturalShrimp/Hydrenesis LLC, a Texas limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the year ended March 31, 2023, the Company had a net loss available for common stockholders of approximately $<span id="xdx_900_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3p0_di_c20220401__20230331_ziTNCprNCeH4" title="Net loss from operation">17,497,000</span>. As of March 31, 2023, the Company had an accumulated deficit of approximately $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20230331_zOP0sK7noTe1" title="Accumulated deficit">167,533,000</span> and a working capital deficit of approximately $<span id="xdx_904_ecustom--WorkingCapitalDeficit_iNI_di_c20230331_zXrBMzT78yM2" title="Working capital deficit">9,339,000</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the year ended March 31, 2023, the Company received net cash proceeds of approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220401__20230331_zyMbPe7rtCze" title="Sale of stock consideration">3,076,000</span> from the sale of common shares (See Note 12), and $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20220401__20230331_zEXWkysbk7Db" title="Proceeds from issuance of notes">1,715,000 </span>proceeds from the issuance of promissory notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently in the process of obtaining the requisite approvals to close a business combination with a special purpose acquisition corporation (“SPAC”) (See Note 17). Upon the closing of such business combination, the Company is expecting to obtain funding for their operations through the cash held by the SPAC’s Trust Account, in addition to any backstop financing that the SPAC may need to pursue in the event that the Trust Account does not have sufficient funds available after redemptions. The Company can provide no assurance that the transactions with the SPAC will be successful or that, even if the business combination is successful, that there will be sufficient funds available from such transaction. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to its common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict its operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter into production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17497000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167533000	usd
CY2023Q1	SHMP	Working Capital Deficit WorkingCapitalDeficit	-9339000	usd
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	3076000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1715000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zNO7OQlSbyC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zjzqZHsibvT5">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18573116	shares
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13101000	usd
CY2023	SHMP	Reclass To Equity Upon Conversion Or Redemption ReclassToEquityUponConversionOrRedemption	-12290000	usd
CY2022	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities	12985000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-116000	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13101000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
CY2022	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability	5910000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3568000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1987000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	355000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
CY2023	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement	20847867	usd
CY2023	SHMP	Change In Fair Value Of Restructed Notes ChangeInFairValueOfRestructedNotes	2842133	usd
CY2023Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote	23690000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The fair value was based on the maturity dates, the interest of 12%, the 15% exit fee, the 2% appreciation fee for an estimated period, and a 40% present value factor
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2022Q4	SHMP	Debt Instrument Exit Fee Percentage DebtInstrumentExitFeePercentage	0.15	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z8IxxPA7Hi4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zdPYQIUk9zDc">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zDzqjeoeCQub" title="Cash, FDIC insured amount">250,000</span>. As of March 31, 2023, the Company’s cash balance did not exceed FDIC coverage. As of March 31, 2022 the Company’s cash balance exceeded FDIC coverage. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2018Q1	SHMP	Partnership Percentage PartnershipPercentage	100%
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	390000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	341500	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	250000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	375000	usd
CY2022	SHMP	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	-856207	usd
CY2022	SHMP	Accounts Payable AccountsPayable	342948	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8925244	usd
CY2022	SHMP	Payments Due On License Agreement PaymentsDueOnLicenseAgreement	-1250000	usd
CY2022	SHMP	Payments Made On License Agreement PaymentsMadeOnLicenseAgreement	-2400000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18935954	usd
CY2023Q1	us-gaap	Land Land	324293	usd
CY2022Q1	us-gaap	Land Land	324293	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5495150	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5611723	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12293112	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10524343	usd
CY2023Q1	SHMP	Automobiles Gross AutomobilesGross	307227	usd
CY2022Q1	SHMP	Automobiles Gross AutomobilesGross	247356	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18419782	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16707715	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3376067	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1909612	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15043715	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2023	us-gaap	Depreciation Depreciation	1795000	usd
CY2022	us-gaap	Depreciation Depreciation	1307000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	625000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	875000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	1000000	usd
CY2023	SHMP	Description For Uplisted Term And Trigger Events DescriptionForUplistedTermAndTriggerEvents	In conjunction with the Merger Agreement, entered into on October 24, 2022, with Yotta Acquisition Corporation (Note 17), on November 4, 2022, the Company entered into a Restructuring Agreement for an Amended and Restated Secured Promissory Note (the “August Note”), through which the August Note was amended and restated in its entirety. The Restructuring Agreement included key modifications, in which i) the Uplist terms were removed, ii) in the event that the Closing of the Merger does not occur on or before December 31, 2022, the then-current Outstanding Balance will be increased by 2% and shall increase by 2% every 30 days thereafter until the Closing or termination of the Merger Agreement, and iii) the outstanding balance of the Convertible Note may be increased by 5% to 15% upon the occurrence of an event of default or failure to obtain the Lender’s consent or notify the Lender for certain major equity related transactions (“Trigger Events”). The Merger has not yet closed, and therefore the 2% of the outstanding balance was increased as of March 31, 2023
CY2022Q4	SHMP	Increase In Outstanding Balance Percentage IncreaseInOutstandingBalancePercentage	0.10	pure
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	99000	usd
CY2022Q2	SHMP	Percentage Of Series E Preferred Shares To One Holder PercentageOfSeriesEPreferredSharesToOneHolder	0.10	pure
CY2022Q1	SHMP	Increase In Series E Preferred Shares To One Holder Based On Certain Rights Shares IncreaseInSeriesEPreferredSharesToOneHolderBasedOnCertainRightsShares	130	shares
CY2022Q1	SHMP	Increase In Series E Preferred Shares To One Holder Based On Certain Rights IncreaseInSeriesEPreferredSharesToOneHolderBasedOnCertainRights	156000	usd
CY2022Q1	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.15	pure
CY2022Q4	us-gaap	Debt Conversion Description DebtConversionDescription	(i) the stated value of $1,200 per share plus any unpaid dividends, multiplied by 1.25, divided by (ii) 80% of the average volume weighted average price of the Company’s common stock during the five trading day period immediately prior to the Closing Date
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	10000000	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3739000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	10000000	shares
CY2021Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.35
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18573116	shares
CY2023	SHMP	Fair Value Of Warrants FairValueOfWarrants	355000	usd
CY2023	SHMP	Decrease In Fair Value Of Warrant DecreaseInFairValueOfWarrant	3568000	usd
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	119000	usd
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	22270	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2022Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.046	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.184	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.256	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.394	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8900000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6022000	usd
CY2023Q1	SHMP	Deferred Tax Assets Other Tax Carryforward DeferredTaxAssetsOtherTaxCarryforward	-279000	usd
CY2022Q1	SHMP	Deferred Tax Assets Other Tax Carryforward DeferredTaxAssetsOtherTaxCarryforward	-350000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8621000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5672000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8621000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5672000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	42500000	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	The carry forwards beginning in tax years 2018 are allowed to be carried forward indefinitely and are to be limited to 80% of the taxable income
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	282000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5192000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2243000	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1727	usd
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q2	us-gaap	Deposits Deposits	52362	usd
CY2021Q2	us-gaap	Security Deposit SecurityDeposit	17454	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	87808	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	87808	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	54709	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	230325	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17332	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	212993	usd
CY2021Q4	SHMP	Shares Issued During Settlement SharesIssuedDuringSettlement	93000000	shares
CY2021Q4	SHMP	Fair Value Of Stock Issued FairValueOfStockIssued	29388000	usd
CY2021Q4	SHMP	Common Share Value CommonShareValue	0.316
CY2022Q1	SHMP	Issued Stock Payable IssuedStockPayable	28494706	shares
CY2022Q1	SHMP	Reclassified Stock Payable ReclassifiedStockPayable	9415950	usd

Files In Submission

Name	View Source	Status
shmp-20230331_cal.xml	Edgar Link	unprocessable
0001493152-23-022546-index-headers.html	Edgar Link	pending
0001493152-23-022546-index.html	Edgar Link	pending
0001493152-23-022546.txt	Edgar Link	pending
0001493152-23-022546-xbrl.zip	Edgar Link	pending
ex10-18.htm	Edgar Link	pending
ex10-18_001.jpg	Edgar Link	pending
ex10-18_002.jpg	Edgar Link	pending
ex10-18_003.jpg	Edgar Link	pending
ex10-18_004.jpg	Edgar Link	pending
ex10-18_005.jpg	Edgar Link	pending
ex10-19.htm	Edgar Link	pending
ex10-1_1.htm	Edgar Link	pending
ex10-20.htm	Edgar Link	pending
ex10-20_001.jpg	Edgar Link	pending
ex10-20_002.jpg	Edgar Link	pending
ex10-20_003.jpg	Edgar Link	pending
ex10-20_004.jpg	Edgar Link	pending
ex10-20_005.jpg	Edgar Link	pending
ex10-20_006.jpg	Edgar Link	pending
ex10-20_007.jpg	Edgar Link	pending
ex10-20_008.jpg	Edgar Link	pending
ex10-20_009.jpg	Edgar Link	pending
ex10-20_010.jpg	Edgar Link	pending
ex10-20_011.jpg	Edgar Link	pending
ex10-20_012.jpg	Edgar Link	pending
ex10-20_013.jpg	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-10.htm	Edgar Link	pending
ex4-11.htm	Edgar Link	pending
ex4-11_001.jpg	Edgar Link	pending
ex4-11_002.jpg	Edgar Link	pending
ex4-11_003.jpg	Edgar Link	pending
ex4-11_004.jpg	Edgar Link	pending
ex4-11_005.jpg	Edgar Link	pending
ex4-12.htm	Edgar Link	pending
ex4-12_001.jpg	Edgar Link	pending
ex4-12_002.jpg	Edgar Link	pending
ex4-12_003.jpg	Edgar Link	pending
ex4-12_004.jpg	Edgar Link	pending
ex4-12_005.jpg	Edgar Link	pending
ex4-13.htm	Edgar Link	pending
ex4-13_001.jpg	Edgar Link	pending
ex4-13_002.jpg	Edgar Link	pending
ex4-13_003.jpg	Edgar Link	pending
ex4-13_004.jpg	Edgar Link	pending
ex4-13_005.jpg	Edgar Link	pending
ex4-14.htm	Edgar Link	pending
ex4-14_001.jpg	Edgar Link	pending
ex4-14_002.jpg	Edgar Link	pending
ex4-14_003.jpg	Edgar Link	pending
ex4-14_004.jpg	Edgar Link	pending
ex4-14_005.jpg	Edgar Link	pending
ex4-15.htm	Edgar Link	pending
ex4-15_001.jpg	Edgar Link	pending
ex4-15_002.jpg	Edgar Link	pending
ex4-15_003.jpg	Edgar Link	pending
ex4-15_004.jpg	Edgar Link	pending
ex4-15_005.jpg	Edgar Link	pending
ex4-16.htm	Edgar Link	pending
ex4-16_001.jpg	Edgar Link	pending
ex4-16_002.jpg	Edgar Link	pending
ex4-16_003.jpg	Edgar Link	pending
ex4-16_004.jpg	Edgar Link	pending
ex4-16_005.jpg	Edgar Link	pending
ex4-17.htm	Edgar Link	pending
ex4-17_001.jpg	Edgar Link	pending
ex4-17_002.jpg	Edgar Link	pending
ex4-17_003.jpg	Edgar Link	pending
ex4-17_004.jpg	Edgar Link	pending
ex4-17_005.jpg	Edgar Link	pending
ex4-18.htm	Edgar Link	pending
ex4-18_001.jpg	Edgar Link	pending
ex4-18_002.jpg	Edgar Link	pending
ex4-18_003.jpg	Edgar Link	pending
ex4-18_004.jpg	Edgar Link	pending
ex4-18_005.jpg	Edgar Link	pending
ex4-19.htm	Edgar Link	pending
ex4-19_001.jpg	Edgar Link	pending
ex4-19_002.jpg	Edgar Link	pending
ex4-19_003.jpg	Edgar Link	pending
ex4-19_004.jpg	Edgar Link	pending
ex4-19_005.jpg	Edgar Link	pending
ex4-20.htm	Edgar Link	pending
ex4-20_001.jpg	Edgar Link	pending
ex4-20_002.jpg	Edgar Link	pending
ex4-20_003.jpg	Edgar Link	pending
ex4-20_004.jpg	Edgar Link	pending
ex4-20_005.jpg	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
ex4-6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20230331.xsd	Edgar Link	pending
shmp-20230331_def.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
shmp-20230331_lab.xml	Edgar Link	unprocessable
shmp-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2023 Q2 Form 10-K Financial Statement

#000149315223022546 Filed on June 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2023 Q2 Form 10-K Financial Statement

#000149315223022546 Filed on June 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp